Special Considerations in the Management of HIV-Infected Patients From Minority Communities

  • Authors: Bisola Ojikutu, MD, MPH; Valerie E. Stone, MD, MPH (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/9/18 (What's New)

Summary

  • M05-730 study compared lopinavir/ritonavir once daily vs twice daily in antiretroviral-naive patients[da Silva 2008]
  • Efficacy did not differ by race
  • Anorexia was significantly more frequent and moderate to severe diarrhea significantly less frequent in nonwhite patients than white patients

Action required